Q9Z0M6 (CD97_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 113.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: CD97 antigen Alternative name(s): CD_antigen=CD97 | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 818 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor potentially involved in both adhesion and signaling processes early after leukocyte activation. Plays an essential role in leukocyte migration. Ref.5 |
| Subunit structure | Forms a heterodimer, consisting of a large extracellular region (alpha subunit) non-covalently linked to a seven-transmembrane moiety (beta subunit). Interacts with complement decay-accelerating factor (DAF). The largest isoform 1) do not interact with DAF. Interacts also with chondroitin sulfate By similarity. Ref.2 |
| Subcellular location | |
| Tissue specificity | Although predominantly expressed by cells of the immune system is expressed ubiquitously, with particularly high levels of expression in the lung and the thymus gland. In the spleen, expression is detected on most myeloid cells and variable portions of T-cells, B-cells and NK cells. In the bone marrow, expressed in nearly all myeloid cells, whereas little if any expression is found on erythroid cells. |
| Induction | Up-regulated during lymphocyte activation. |
| Domain | The first two EGF domains mediate the interaction with DAF. A third tandemly arranged EGF domain is necessary for the structural integrity of the binding region By similarity. Binding to chondroitin sulfate is mediated by the fourth EGF domain By similarity. |
| Post-translational modification | Proteolytically cleaved into 2 subunits, an extracellular alpha subunit and a seven-transmembrane subunit By similarity. |
| Sequence similarities | Belongs to the G-protein coupled receptor 2 family. LN-TM7 subfamily. Contains 4 EGF-like domains. Contains 1 GPS domain. |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9Z0M6-1) Also known as: EGF(1,2,X,3,4); This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9Z0M6-2) Also known as: EGF(1,2,4); The sequence of this isoform differs from the canonical sequence as follows: 120-213: Missing. | ||||||
| Isoform 3 (identifier: Q9Z0M6-3) Also known as: EGF(1,2,3,4); The sequence of this isoform differs from the canonical sequence as follows: 120-164: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 23 | 23 | Potential | ||||||||
| Chain | 24 – 818 | 795 | CD97 antigen | PRO_0000012869 | |||||||
Regions | |||||||||||
| Topological domain | 24 – 533 | 510 | Extracellular Potential | ||||||||
| Transmembrane | 534 – 554 | 21 | Helical; Name=1; Potential | ||||||||
| Topological domain | 555 – 562 | 8 | Cytoplasmic Potential | ||||||||
| Transmembrane | 563 – 583 | 21 | Helical; Name=2; Potential | ||||||||
| Topological domain | 584 – 602 | 19 | Extracellular Potential | ||||||||
| Transmembrane | 603 – 623 | 21 | Helical; Name=3; Potential | ||||||||
| Topological domain | 624 – 637 | 14 | Cytoplasmic Potential | ||||||||
| Transmembrane | 638 – 658 | 21 | Helical; Name=4; Potential | ||||||||
| Topological domain | 659 – 679 | 21 | Extracellular Potential | ||||||||
| Transmembrane | 680 – 700 | 21 | Helical; Name=5; Potential | ||||||||
| Topological domain | 701 – 723 | 23 | Cytoplasmic Potential | ||||||||
| Transmembrane | 724 – 744 | 21 | Helical; Name=6; Potential | ||||||||
| Topological domain | 745 – 752 | 8 | Extracellular Potential | ||||||||
| Transmembrane | 753 – 773 | 21 | Helical; Name=7; Potential | ||||||||
| Topological domain | 774 – 818 | 45 | Cytoplasmic Potential | ||||||||
| Domain | 27 – 68 | 42 | EGF-like 1 | ||||||||
| Domain | 69 – 119 | 51 | EGF-like 2; calcium-binding Potential | ||||||||
| Domain | 165 – 213 | 49 | EGF-like 3; calcium-binding Potential | ||||||||
| Domain | 214 – 261 | 48 | EGF-like 4; calcium-binding Potential | ||||||||
| Domain | 479 – 524 | 46 | GPS | ||||||||
Sites | |||||||||||
| Site | 513 – 514 | 2 | Cleavage By similarity | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 814 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 816 | 1 | Phosphoserine By similarity | ||||||||
| Glycosylation | 44 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 112 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 227 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 299 | 1 | N-linked (GlcNAc...) Ref.6 Ref.7 | ||||||||
| Glycosylation | 395 | 1 | N-linked (GlcNAc...) Ref.6 Ref.7 | ||||||||
| Glycosylation | 407 | 1 | N-linked (GlcNAc...) Ref.6 Ref.7 | ||||||||
| Glycosylation | 461 | 1 | N-linked (GlcNAc...) Ref.6 | ||||||||
| Glycosylation | 502 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 31 ↔ 41 | By similarity | |||||||||
| Disulfide bond | 35 ↔ 47 | By similarity | |||||||||
| Disulfide bond | 49 ↔ 67 | By similarity | |||||||||
| Disulfide bond | 73 ↔ 86 | By similarity | |||||||||
| Disulfide bond | 80 ↔ 95 | By similarity | |||||||||
| Disulfide bond | 97 ↔ 118 | By similarity | |||||||||
| Disulfide bond | 169 ↔ 182 | By similarity | |||||||||
| Disulfide bond | 176 ↔ 191 | By similarity | |||||||||
| Disulfide bond | 193 ↔ 212 | By similarity | |||||||||
| Disulfide bond | 218 ↔ 231 | By similarity | |||||||||
| Disulfide bond | 225 ↔ 240 | By similarity | |||||||||
| Disulfide bond | 242 ↔ 260 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 120 – 213 | 94 | Missing in isoform 2. | VSP_009413 | |||||||
| Alternative sequence | 120 – 164 | 45 | Missing in isoform 3. | VSP_009414 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 3 | 1 | G → S in CAB38246. Ref.1 | ||||||||
| Sequence conflict | 28 | 1 | S → I in CAB38246. Ref.1 | ||||||||
| Sequence conflict | 320 | 1 | Q → E in AAH06676. Ref.3 | ||||||||
| Sequence conflict | 506 | 1 | F → S in AAF67800. Ref.2 | ||||||||
| Sequence conflict | 599 | 1 | M → V in AAH06676. Ref.3 | ||||||||
| Sequence conflict | 726 | 1 | A → S Ref.3 | ||||||||
| Sequence conflict | 726 | 1 | A → S Ref.4 | ||||||||
| Sequence conflict | 796 | 1 | F → I in BAB25461. Ref.4 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and characterization of mouse CD97." Hamann J., van Zventer C., Bijl A., Molenaar C., Tesselaar K., van Lier R.A.W. Int. Immunol. 12:439-448(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3). |
| [2] | "Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55)." Qian Y.-M., Haino M., Kelly K., Song W.-C. Immunology 98:303-311(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), INTERACTION WITH DAF, SUBCELLULAR LOCATION. Tissue: Testis. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [4] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 607-818. Strain: C57BL/6J. Tissue: Small intestine. |
| [5] | "The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense." Leemans J.C., te Velde A.A., Florquin S., Bennink R.J., de Bruin K., van Lier R.A.W., van der Poll T., Hamann J. J. Immunol. 172:1125-1131(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [6] | "The mouse C2C12 myoblast cell surface N-linked glycoproteome: identification, glycosite occupancy, and membrane orientation." Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I., Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E., Wollscheid B. Mol. Cell. Proteomics 8:2555-2569(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-299; ASN-395; ASN-407 AND ASN-461, MASS SPECTROMETRY. Tissue: Myoblast. |
| [7] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-299; ASN-395 AND ASN-407, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | Y18365 mRNA. Translation: CAB38246.1. AF146344 mRNA. Translation: AAF67800.1. BC006676 mRNA. Translation: AAH06676.1. AK008101 mRNA. Translation: BAB25461.1. |
| IPI | IPI00399798. IPI00399799. IPI00399800. |
| RefSeq | NP_001156501.1. NM_001163029.1. |
| UniGene | Mm.334648. |
3D structure databases | |
| ProteinModelPortal | Q9Z0M6. |
| SMR | Q9Z0M6. Positions 31-261. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 10090.ENSMUSP00000075240. |
Protein family/group databases | |
| MEROPS | S63.036. |
| GPCRDB | Search... |
PTM databases | |
| PhosphoSite | Q9Z0M6. |
Proteomic databases | |
| PaxDb | Q9Z0M6. |
| PRIDE | Q9Z0M6. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000002964; ENSMUSP00000002964; ENSMUSG00000002885. |
| GeneID | 26364. |
| KEGG | mmu:26364. |
| UCSC | uc009mlc.2. mouse. uc012ggt.1. mouse. |
Organism-specific databases | |
| CTD | 976. |
| MGI | MGI:1347095. Cd97. |
Phylogenomic databases | |
| eggNOG | NOG320737. |
| GeneTree | ENSGT00650000093107. |
| HOGENOM | HOG000294115. |
| HOVERGEN | HBG048917. |
| InParanoid | Q9Z0M6. |
| KO | K08446. |
| OrthoDB | EOG45X7WF. |
Gene expression databases | |
| ArrayExpress | Q9Z0M6. |
| Bgee | Q9Z0M6. |
| CleanEx | MM_CD97. |
| Genevestigator | Q9Z0M6. |
| GermOnline | ENSMUSG00000002885. Mus musculus. |
Family and domain databases | |
| InterPro | IPR000742. EG-like_dom. IPR001881. EGF-like_Ca-bd. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR018097. EGF_Ca-bd_CS. IPR017981. GPCR_2-like. IPR003056. GPCR_2_CD97. IPR000832. GPCR_2_secretin-like. IPR000203. GPS_dom. [Graphical view] |
| Pfam | PF00002. 7tm_2. 1 hit. PF07645. EGF_CA. 3 hits. PF01825. GPS. 1 hit. [Graphical view] |
| PRINTS | PR01278. CD97PROTEIN. PR00249. GPCRSECRETIN. |
| SMART | SM00181. EGF. 1 hit. SM00179. EGF_CA. 3 hits. SM00303. GPS. 1 hit. [Graphical view] |
| PROSITE | PS00010. ASX_HYDROXYL. 3 hits. PS50026. EGF_3. 3 hits. PS01187. EGF_CA. 3 hits. PS00650. G_PROTEIN_RECEP_F2_2. False negative. PS50261. G_PROTEIN_RECEP_F2_4. 1 hit. PS50221. GPS. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | CD97. mouse. |
| NextBio | 304231. |
| SOURCE | Search... |
Entry information
| Entry name | CD97_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q9Z0M6 Secondary accession number(s): Q923A1, Q9CVI5, Q9JLQ8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| 7-transmembrane G-linked receptors List of 7-transmembrane G-linked receptor entries |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
